Unresectable gastric cancer with gastric outlet obstruction and distant metastasis responding to intraperitoneal and folfox chemotherapy after palliative laparoscopic gastrojejunostomy: Report of a case

World Journal of Surgical Oncology

Volumn 8, Issue , 2010, Pages

  Park, Joong Min ^a,b   Chi, Kyong Choun ^a,b  

^a Chung Ang University College of Medicine   (South Korea)

^b Chung Ang University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CARBOPLATIN; CARCINOEMBRYONIC ANTIGEN; DOCETAXEL; FLUOROURACIL; OXALIPLATIN; ANTINEOPLASTIC AGENT; FOLINIC ACID; PLATINUM COMPLEX;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISTANT METASTASIS; GASTRECTOMY; GASTROJEJUNOSTOMY; GASTROSCOPY; HUMAN; INOPERABLE CANCER; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; MALE; POSTOPERATIVE CARE; STOMACH ADENOCARCINOMA; STOMACH OBSTRUCTION; TREATMENT RESPONSE; ADENOCARCINOMA; INTRAPERITONEAL DRUG ADMINISTRATION; LAPAROSCOPY; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PALLIATIVE THERAPY; PATHOLOGY; PROGNOSIS; STOMACH BYPASS; STOMACH TUMOR;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FLUOROURACIL; GASTRIC BYPASS; GASTRIC OUTLET OBSTRUCTION; HUMANS; INJECTIONS, INTRAPERITONEAL; LAPAROSCOPY; LEUCOVORIN; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; PALLIATIVE CARE; PROGNOSIS; STOMACH NEOPLASMS;

EID: 78650204055     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-8-109     Document Type: Article

References (17)

1. Yonemura Y, Bandou E, Sawa T, Yoshimitsu Y, Endou Y, Sasaki T, Sugarbaker PH. Neoadjuvant treatment of gastric cancer with peritoneal dissemination. Eur J Surg Oncol 2006, 32:661-665. 10.1016/j.ejso.2006.03.007, 16621433.
2. Mizutani S, Oyama T, Hatanaka N, Uchikoshi F, Yoshidome K, Tori M, Ueshima S, Nakahara M, Nakao K. Unresectable gastric cancer with multiple liver metastases effectively treated with combined paclitaxel and doxifluridine chemotherapy. Int J Clin Oncol 2006, 11:471-474. 10.1007/s10147-006-0597-y, 17180517.
3. Okabe H, Ueda S, Obama K, Hosogi H, Sakai Y. Induction Chemotherapy with S-1 Plus Cisplatin Followed by Surgery for Treatment of Gastric Cancer with Peritoneal Dissemination. Ann Surg Oncol 2009,
4. Mori S, Kishimoto H, Tauchi K, Higuchi K. Histological complete response in advanced gastric cancer after 2 weeks of S-1 administration as neoadjuvant chemotherapy. Gastric Cancer 2006, 9:136-139. 10.1007/s10120-005-0358-z, 16767370.
5. Yonemura Y, Endou Y, Shinbo M, Sasaki T, Hirano M, Mizumoto A, Matsuda T, Takao N, Ichinose M, Mizuno M, et al. Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery. J Surg Oncol 2009, 100:311-316. 10.1002/jso.21324, 19697437.
6. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982, 5:649-655. 10.1097/00000421-198212000-00014, 7165009.
7. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009, 45:228-247. 10.1016/j.ejca.2008.10.026, 19097774.
8. Sugarbaker PH, Yonemura Y. Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure. Oncology 2000, 58:96-107. 10.1159/000012086, 10705236.
9. Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 2008, 9:215-221. 10.1016/S1470-2045(08)70035-4, 18282805.
10. Lordick F, Lorenzen S, Stollfuss J, Vehling-Kaiser U, Kullmann F, Hentrich M, Zumschlinge R, Dietzfelbinger H, Thoedtmann J, Hennig M, et al. Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer. Br J Cancer 2005, 93:190-194. 10.1038/sj.bjc.6602697, 2361546, 16012522.
11. Liu ZF, Guo QS, Zhang XQ, Yang XG, Guan F, Fu Z, Wang MY. Biweekly oxaliplatin in combination with continuous infusional 5-fluorouracil and leucovorin (modified FOLFOX-4 regimen) as first-line chemotherapy for elderly patients with advanced gastric cancer. Am J Clin Oncol 2008, 31:259-263. 10.1097/COC.0b013e31815d43ee, 18525305.
12. Cavanna L, Artioli F, Codignola C, Lazzaro A, Rizzi A, Gamboni A, Rota L, Rodino C, Boni F, Iop A, Zaniboni A. Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic gastric cancer (MGC). Am J Clin Oncol 2006, 29:371-375. 10.1097/01.coc.0000221358.57089.f2, 16891864.
13. Wang LB, Shen JG, Xu CY, Chen WJ, Song XY, Yuan XM. Neoadjuvant chemotherapy versus surgery alone for locally advanced gastric cancer: a retrospective comparative study. Hepatogastroenterology 2008, 55:1895-1898.
14. D'Ugo D, Persiani R, Rausei S, Biondi A, Vigorita V, Boccia S, Ricci R. Response to neoadjuvant chemotherapy and effects of tumor regression in gastric cancer. Eur J Surg Oncol 2006, 32:1105-1109.
15. Ajani JA, Winter K, Okawara GS, Donohue JH, Pisters PW, Crane CH, Greskovich JF, Anne PR, Bradley JD, Willett C, Rich TA. Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response. J Clin Oncol 2006, 24:3953-3958. 10.1200/JCO.2006.06.4840, 16921048.
16. Park SH, Mok YJ, Kim JH, Park SS, Kim SJ, Kim CS. Clinical significance of gastric outlet obstruction on the oncologic and surgical outcomes of radical surgery for carcinoma of the distal stomach. J Surg Oncol 2009, 100:215-221. 10.1002/jso.21256, 19235783.
17. Jeurnink SM, Steyerberg EW, Hooft JE, van Eijck CH, Schwartz MP, Vleggaar FP, Kuipers EJ, Siersema PD. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc 2009,